{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "29217838",
  "DateCompleted": {
    "Year": "2017",
    "Month": "12",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "11",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "12",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/nrc.2017.102"
    ],
    "Journal": {
      "ISSN": "1474-1768",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "1",
        "PubDate": {
          "Year": "2018",
          "Month": "Jan"
        }
      },
      "Title": "Nature reviews. Cancer",
      "ISOAbbreviation": "Nat Rev Cancer"
    },
    "ArticleTitle": "An evolutionary perspective on field cancerization.",
    "Pagination": {
      "StartPage": "19",
      "EndPage": "32",
      "MedlinePgn": "19-32"
    },
    "Abstract": {
      "AbstractText": [
        "Tumorigenesis begins long before the growth of a clinically detectable lesion and, indeed, even before any of the usual morphological correlates of pre-malignancy are recognizable. Field cancerization, which is the replacement of the normal cell population by a cancer-primed cell population that may show no morphological change, is now recognized to underlie the development of many types of cancer, including the common carcinomas of the lung, colon, skin, prostate and bladder. Field cancerization is the consequence of the evolution of somatic cells in the body that results in cells that carry some but not all phenotypes required for malignancy. Here, we review the evidence of field cancerization across organs and examine the biological mechanisms that drive the evolutionary process that results in field creation. We discuss the clinical implications, principally, how measurements of the cancerized field could improve cancer risk prediction in patients with pre-malignant disease."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Tumour Biology, Barts Cancer Institute, EC1M 6BQ London, UK."
          }
        ],
        "LastName": "Curtius",
        "ForeName": "Kit",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Tumour Biology, Barts Cancer Institute, EC1M 6BQ London, UK."
          }
        ],
        "LastName": "Wright",
        "ForeName": "Nicholas A",
        "Initials": "NA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Tumour Biology, Barts Cancer Institute, EC1M 6BQ London, UK."
          }
        ],
        "LastName": "Graham",
        "ForeName": "Trevor A",
        "Initials": "TA"
      }
    ],
    "GrantList": [
      {
        "GrantID": "202778/Z/16/Z",
        "Acronym": "WT_",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nat Rev Cancer",
    "NlmUniqueID": "101124168",
    "ISSNLinking": "1474-175X"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Cell Transformation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Evolution, Molecular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phenotype"
    }
  ]
}